Cargando…
Peritoneal metastasis of colorectal cancer (pmCRC): identification of predictive molecular signatures by a novel preclinical platform of matching pmCRC PDX/PD3D models
Autores principales: | Dahlmann, Mathias, Gambara, Guido, Brzezicha, Bernadette, Popp, Oliver, Pachmayr, Eva, Wedeken, Lena, Pflaume, Alina, Mokritzkij, Margarita, Gül-Klein, Safak, Brandl, Andreas, Schweiger-Eisbacher, Caroline, Mertins, Philipp, Hoffmann, Jens, Keilholz, Ulrich, Walther, Wolfgang, Regenbrecht, Christian, Rau, Beate, Stein, Ulrike |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529724/ https://www.ncbi.nlm.nih.gov/pubmed/34670579 http://dx.doi.org/10.1186/s12943-021-01430-7 |
Ejemplares similares
-
Patient-derived xenograft (PDX) models of colorectal carcinoma (CRC) as a platform for chemosensitivity and biomarker analysis in personalized medicine
por: Rivera, Maria, et al.
Publicado: (2020) -
Combinatorial treatment with statins and niclosamide prevents CRC dissemination by unhinging the MACC1-β-catenin-S100A4 axis of metastasis
por: Kortüm, Benedikt, et al.
Publicado: (2022) -
Dynamic alterations of genome and transcriptome in KRAS G13D mutant CRC PDX model treated with cetuximab
por: Zhang, Hangyu, et al.
Publicado: (2020) -
CRC handbook of microbiology
Publicado: (1988) -
Precision Oncology Beyond Genomics: The Future Is Here—It Is Just Not Evenly Distributed
por: Pfohl, Ulrike, et al.
Publicado: (2021)